Terms ending in 2042
Every in-force patent on CureVac AG's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,492,425 | Methods for RNA Analysis In force · High confidence | Curevac SE | In force | High confidence | |
| US 12,528,855 | Kras Variant Mrna Molecules In force · High confidence | Curevac SE | In force | High confidence | |
| US 12,371,646 | Bioreactor for RNA in Vitro Transcription In force · High confidence | Curevac Manufacturing GmbH | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.